Ono Pharmaceutical Co., Ltd.
OPHLF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $4,863 | $631,717 | $781,185 | $709,783 |
| - Cash | $1,231 | $138,991 | $204,567 | $160,982 |
| + Debt | $882 | $138,111 | $146,678 | $154,286 |
| Enterprise Value | $4,514 | $630,837 | $723,296 | $703,087 |
| Revenue | $876 | $127,536 | $112,309 | $134,223 |
| % Growth | -99.3% | 13.6% | -16.3% | – |
| Gross Profit | $640 | $90,523 | $67,072 | $88,387 |
| % Margin | 73% | 71% | 59.7% | 65.9% |
| EBITDA | $271 | $31,233 | -$5,788 | $24,045 |
| % Margin | 30.9% | 24.5% | -5.2% | 17.9% |
| Net Income | $152 | $17,673 | -$6,545 | $14,951 |
| % Margin | 17.4% | 13.9% | -5.8% | 11.1% |
| EPS Diluted | 0.32 | 37.58 | -13.97 | 31.81 |
| % Growth | -99.1% | 369% | -143.9% | – |
| Operating Cash Flow | $346 | $3,373 | $38,996 | $8,740 |
| Capital Expenditures | -$11 | -$2,250 | -$1,421 | -$1,204 |
| Free Cash Flow | $335 | $1,123 | $37,575 | $7,536 |